| |
| |
|
| Insider
Information: |
Farrow Jeffrey S |
| Relationship: |
Chief Financial Officer |
| City: |
South San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 0.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Renovis Inc |
RNVS |
V.P., Finance and CAO |
2008-05-02 |
0 |
|
0 |
Premium* |
|
|
Hyperion Therapeutics Inc |
HPTX |
CFO |
2015-05-07 |
0 |
2014-03-11 |
0 |
Premium* |
|
|
Global Blood Therapeutics, Inc. |
GBT |
Chief Financial Officer |
2022-10-05 |
0 |
2017-08-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GBT |
Global Blood Therapeutics... |
Chief Financial Officer |
• – – |
2022-10-05 |
4 |
D |
$0.00 |
$0 |
D/D |
(26,739) |
0 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Chief Financial Officer |
• – – |
2022-09-27 |
4 |
OE |
$16.40 |
$387,909 |
D/D |
23,653 |
26,739 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Chief Financial Officer |
• – – |
2022-09-01 |
4 |
S |
$68.00 |
$2,137,988 |
D/D |
(31,441) |
3,086 |
0 |
% |
|
| GBT |
Global Blood Therapeutics... |
Chief Financial Officer |
• – – |
2022-09-01 |
4 |
D |
$68.15 |
$128,463 |
D/D |
(1,885) |
34,527 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Chief Financial Officer |
• – – |
2022-09-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,971 |
36,412 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Chief Financial Officer |
• – – |
2022-08-01 |
4 |
D |
$32.40 |
$68,882 |
D/D |
(2,126) |
31,441 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Chief Financial Officer |
• – – |
2022-08-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,145 |
33,567 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Chief Financial Officer |
• – – |
2022-03-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,763 |
28,737 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Chief Financial Officer |
• – – |
2022-03-01 |
4 |
D |
$29.87 |
$39,279 |
D/D |
(1,315) |
27,422 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Chief Financial Officer |
• – – |
2022-02-01 |
4 |
D |
$29.33 |
$132,161 |
D/D |
(4,506) |
25,974 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Chief Financial Officer |
• – – |
2022-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,020 |
30,480 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Chief Financial Officer |
• – – |
2021-09-01 |
4 |
D |
$29.85 |
$40,895 |
D/D |
(1,370) |
21,460 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Chief Financial Officer |
• – – |
2021-09-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,762 |
22,830 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Chief Financial Officer |
• – – |
2021-08-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,020 |
24,422 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Chief Financial Officer |
• – – |
2021-08-01 |
4 |
D |
$27.33 |
$118,995 |
D/D |
(4,354) |
20,068 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Chief Financial Officer |
• – – |
2021-02-01 |
4 |
D |
$49.49 |
$290,259 |
D/D |
(5,865) |
15,402 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Chief Financial Officer |
• – – |
2021-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,083 |
21,267 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Chief Financial Officer |
• – – |
2020-08-01 |
4 |
D |
$67.48 |
$401,236 |
D/D |
(5,946) |
9,184 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Chief Financial Officer |
• – – |
2020-08-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
12,082 |
15,130 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Chief Financial Officer |
• – – |
2020-07-13 |
4 |
AS |
$75.00 |
$1,140,600 |
D/D |
(15,208) |
3,048 |
0 |
% |
|
| GBT |
Global Blood Therapeutics... |
Chief Financial Officer |
• – – |
2020-06-09 |
4 |
AS |
$67.00 |
$1,018,936 |
D/D |
(15,208) |
18,256 |
0 |
% |
|
| GBT |
Global Blood Therapeutics... |
Chief Financial Officer |
• – – |
2020-02-01 |
4 |
D |
$65.26 |
$287,013 |
D/D |
(4,398) |
33,464 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Chief Financial Officer |
• – – |
2020-02-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,063 |
37,862 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Chief Financial Officer |
• – – |
2019-12-13 |
4 |
D |
$76.88 |
$190,586 |
D/D |
(2,479) |
28,799 |
0 |
- |
|
| GBT |
Global Blood Therapeutics... |
Chief Financial Officer |
• – – |
2019-12-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
31,278 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
